Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-26-001832
Filing Date
2026-03-31
Accepted
2026-03-31 16:13:53
Documents
88
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K vnrx_10k.htm   iXBRL 10-K 2605059
2 SUBSIDIARIES vnrx_211.htm EX-21.1 4750
3 CONSENT vnrx_231.htm EX-23.1 2303
4 CERTIFICATION vnrx_311.htm EX-31.1 12884
5 CERTIFICATION vnrx_312.htm EX-31.2 12965
6 CERTIFICATION vnrx_321.htm EX-32.1 5436
  Complete submission text file 0001477932-26-001832.txt   12376080

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20251231.xsd EX-101.SCH 121932
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20251231_lab.xml EX-101.LAB 597839
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20251231_cal.xml EX-101.CAL 62555
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20251231_pre.xml EX-101.PRE 549089
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20251231_def.xml EX-101.DEF 401398
92 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10k_htm.xml XML 2656095
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (512) 774-8930
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36833 | Film No.: 26821969
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)